Description
Interpreting the flexibilities under the TRIPS agreement.- Intellectual Property Exhaustion and Parallel Imports of Pharmaceuticals: A Comparative and Critical Review.- Compulsory license and government use.- Access to genome editing technologies.- Bolar exception.- Patent oppositions in India.- Protection of clinical test data.- Courts and Pharmaceutical Patents.- Robust Patent Examination or Deep Harmonization? Cooperation and Work Sharing between Patent Offices .- IPRs, Competition Law and excessive pricing of medicines.- The impact of TRIPS plus rules.- Patent Linkages and its Impact on Access to Medicines.
Author: Carlos M. Correa
Publisher: Springer
Published: 10/28/2021
Pages: 369
Binding Type: Hardcover
Weight: 1.56lbs
Size: 9.21h x 6.14w x 0.88d
ISBN13: 9783030831134
ISBN10: 3030831132
BISAC Categories:
- Law | International
- Medical | General
- Business & Economics | Economics | General
About the Author
Prof. Dr. Carlos María Correa is executive director of the South Centre, Geneva. He is a renowned international authority on intellectual property and technology issues.
Professor Correa has worked with the Argentine government and has been the director of the Center for Interdisciplinary Studies on Industrial Property and Economics (CEIDIE) in the Law Faculty at the University of Buenos Aires. He was a member of the UK Commission on Intellectual Property Rights, the Commission on Intellectual Property Rights, Innovation and Public Health established by the World Health Assembly, and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture.
Professor Correa has been a visiting professor in postgraduate courses of several universities and consultant to various regional and international organisations. He has advised several governments on intellectual property, innovation policy and public health. He is the author of several books and numerous articles.Professor Correa is both a lawyer and economist from the University of Buenos Aires and holds a PhD in Law from the University of Buenos Aires.
Prof. Dr. Dr. h.c. Reto M. Hilty is director at the Max Planck Institute for Competition and Innovation Munich and full professor ad personam at the University of Zurich.